Filter
1140
Text search:
Guidelines
Tuberculose
Featured
Recommendations
118
New Publications
515
Language
Document type
No document type
786
Guidelines
166
Studies & Reports
57
Manuals
44
Strategic & Response Plan
32
Fact sheets
18
Training Material
17
Situation Updates
8
Resource Platforms
6
Brochures
3
Infographics
3
Countries / Regions
India
114
Tanzania
61
Kenya
44
Brazil
40
Nigeria
35
Nepal
35
Indonesia
30
Uganda
29
Malawi
29
Zambia
28
Argentina
28
Congo, Democratic Republic of
26
Senegal
25
Ethiopia
25
Bangladesh
24
Paraguay
23
Peru
21
Colombia
21
Mozambique
20
Ghana
19
South Africa
19
Cambodia
18
Lesotho
17
Myanmar / Burma
16
Burkina Faso
15
Rwanda
15
Namibia
13
Philippines
12
Benin
12
El Salvador
12
Venezuela
12
Haiti
11
Liberia
10
Central African Republic
10
Bolivia
10
Chile
9
Latin America and the Carribbean
9
Sierra Leone
8
Botswana
8
Madagascar
8
Western and Central Europe
7
Africa
7
Zimbabwe
6
Ukraine
6
Ecuador
6
Angola
6
Global
6
Guinea-Bissau
5
Cameroon
5
Pakistan
5
Russia
4
Eswatini/ Swaziland
3
South–East Asia Region
3
Eastern Europe
3
Mali
2
Togo
2
Burundi
2
West and Central Africa
2
Asia
2
Timor Leste/ East Timor
2
Belgium
2
Côte d’Ivoire / Ivory Coast
1
Niger
1
South Sudan
1
Afghanistan
1
Dominican Republic
1
North Macedonia
1
Sri Lanka
1
East and Southern Africa
1
Western Pacific Region
1
Luxembourg
1
Bhutan
1
Djibouti
1
Armenia
1
Southern Africa
1
Congo-Brazzaville
1
Canada
1
Georgia
1
Uruguay
1
Jamaica
1
France
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
925
Clinical Guidelines
108
Women & Child Health
17
Public Health
12
Pharmacy & Technologies
11
Key Resources
10
Capacity Building
9
Toolboxes
TB
291
HIV
58
COVID-19
32
Caregiver
10
Refugee
8
AMR
8
Pharmacy
7
NTDs
7
Ebola
6
Polio
5
Conflict
3
Rapid Response
3
Zika
3
Planetary Health
2
Disability
1
Natural Hazards
1
Mental Health
1
Global Health Education
1
NCDs
1
National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD ...
The term "Programmatic Management of Drug Resistant TB" (PMD ...
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. More
...
Accessed June 17,2019
1PEP GUIDELINES | 2019 EDITION. The prevalence of both HIV and Hepatitis B is high in South Africa therefore there is a significant risk of acquiring these infections following exposure to infected material. Studies suggest that post- exposure proph
...
These guidelines were developed as part of Kenya's fast-track plan to end AIDS among adolescents and young people. Based on research into adolescent and young key populations in Kenya and elsewhere, they outline a package of HIV prevention services,
...
These guidelines provide a framework for effective action to facilitate access to safe and ethical
testing services for different population groups. The implementation of the a comprehensive
approach, known as HIV Testing Services (HTS) is cardina
...
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
The manual is written for clinicians working at the district hospital (first-level referral care) who diagnose and manage sick adolescents and adults in resource constrained settings. It aims to support clinical reasoning, and to provide an effective clinical approach and protocols for the managemen
...
Evidence to decision framework
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
